Dr. David C. Beyer spoke at the 23rd annual Perspectives in Urology Point • Counterpoint meeting on Friday, November 14, 2014 on “Updates in Radiation (Alpha, Beta, Gamma, Photon, Proton).”

 

Keywords: radiation (alpha, beta, gamma, photon, proton), prostate cancer

How to cite: Beyer, David C. “Updates in Radiation (Alpha, Beta, Gamma, Photon, Proton)” Grand Rounds in Urology. July 23, 2015. Accessed Mar 2024. https://grandroundsinurology.com/prostate-cancer-david-c-beyer-updates-in-radiation/.

References

Efstathiou JA, Trofimov AV, Zietman AL. Life, liberty, and the pursuit of protons: an evidence-based review of the role of particle therapy in the treatment of prostate cancer. Cancer J. 2009 Jul-Aug;15(4):312-8.
http://www.ncbi.nlm.nih.gov/pubmed/19672148

Fonteyne V, Soete G, Arcangeli S, et al. Hypofractionated high-dose radiation therapy for prostate cancer: long-term results of a multi-institutional phase II trial. Int J Radiat Oncol Biol Phys. 2012 Nov 15;84(4):e483-90.
http://www.ncbi.nlm.nih.gov/pubmed/23243199

Kupelian PA, Willoughby TR, Reddy CA, et al. Hypofractionated intensity-modulated radiotherapy (70 Gy at 2.5 Gy per fraction) for localized prostate cancer: Cleveland Clinic experience. Int J Radiat Oncol Biol Phys. 2007 Aug 1;68(5):1424-30.
http://www.ncbi.nlm.nih.gov/pubmed/17544601

Leborgne F, Fowler J. Late outcomes following hypofractionated conformal radiotherapy vs. standard fractionation for localized prostate cancer: a nonrandomized contemporary comparison. Int J Radiat Oncol Biol Phys. 2009 Aug 1;74(5):1441-6.
http://www.ncbi.nlm.nih.gov/pubmed/19395194

Rusthoven CG, Carlson JA, Waxweiler TV, et al. The impact of definitive local therapy for lymph node-positive prostate cancer: a population-based study. Int J Radiat Oncol Biol Phys. 2014 Apr 1;88(5):1064-73.
http://www.ncbi.nlm.nih.gov/pubmed/24661660

Swisher-McClure S, Pollack CE, Christodouleas JP, et al. Variation in use of androgen suppression with external-beam radiotherapy for nonmetastatic prostate cancer. Int J Radiat Oncol Biol Phys. 2012 May 1;83(1):8-15.
http://www.ncbi.nlm.nih.gov/pubmed/22079721

Thames HD, Suit HD. Tumor radioresponsiveness versus fractionation sensitivity. Int J Radiat Oncol Biol Phys. 1986 Apr;12(4):687-91.
http://www.ncbi.nlm.nih.gov/pubmed/3700173

Tward JD, Kokeny KE, Shrieve DC. Radiation therapy for clinically node-positive prostate adenocarcinoma is correlated with improved overall and prostate cancer-specific survival. Pract Radiat Oncol. 2013 Jul-Sep;3(3):234-40.
http://www.ncbi.nlm.nih.gov/pubmed/24674370

Yu JB, Soulos PR, Herrin J, et al. Proton versus intensity-modulated radiotherapy for prostate cancer: patterns of care and early toxicity. J Natl Cancer Inst. 2013 Jan 2;105(1):25-32.
http://www.ncbi.nlm.nih.gov/pubmed/23243199